Answers are grounded in this paper and cite their sources.
In this study, we report a transfer hydrogenation protocol that utilizes borane-ammonia (H₃N-BH₃) as the hydrogen source and a commercially available RuCl₃·xH₂O precatalyst for the selective aromatic reduction of quinolines, quinoxalines, pyridines, pyrazines, indoles, benzofurans, and furan derivatives to form the corresponding alicyclic heterocycles in good to excellent isolated yields. Applications of this straightforward protocol include the efficient preparation of useful key pharmaceutical intermediates, such as donepezil and flumequine, including a biologically active compound.
No takes yet. Share an insight, caveat, or question.
Bhatt et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: